People researching Semax or Selank almost always run into Lion’s Mane, Reishi, and Cordyceps at some point — they get recommended in the same nootropic-stacking communities and marketed for overlapping goals. But they work completely differently, and the evidence quality varies a lot between them. Here’s an honest comparison.

Two Different Categories, One Overlapping Goal

Cognitive peptides like Semax are synthetic sequences with a specific, defined mechanism — Semax is an ACTH(4-10) fragment analog studied for upregulating BDNF and NGF through a known pathway. Functional mushrooms aren’t peptides at all: they’re whole-organism extracts containing dozens of bioactive compounds — triterpenes, polysaccharides, hericenones, erinacines, cordycepin — that act on the body through multiple, less precisely mapped mechanisms at once. One important practical difference: Lion’s Mane, Reishi, and Cordyceps are legal dietary supplements sold for human consumption, unlike the “research use only” peptides discussed elsewhere on this site.

Lion’s Mane vs. Semax: The Closest Mechanistic Overlap

Of the three mushrooms, Lion’s Mane (Hericium erinaceus) has the most direct overlap with Semax’s mechanism. It contains two classes of NGF-inducing compounds: hericenones (in the fruiting body) and erinacines (in the mycelium), with erinacine A showing the strongest NGF-inducing activity and confirmed to cross the blood-brain barrier in animal models — the same nerve growth factor pathway Semax is studied for upregulating.

Human trial data exists but is mixed and mostly small-scale. A 16-week trial in adults with mild cognitive impairment found improvement at weeks 8, 12, and 16 with 3g/day H. erinaceus — but the effect reversed 4 weeks after stopping supplementation. A separate 49-week trial using erinacine A-enriched extract in mild Alzheimer’s patients found improvement on the Mini-Mental State Examination at week 49. Both are real, published, positive results — but both are also small trials, and the MCI study’s reversal on discontinuation is a meaningful caveat that gets left out of most marketing copy.

Reishi: A Different Mechanism, Thinner Human Evidence

Reishi (Ganoderma lucidum) doesn’t work through NGF induction the way Lion’s Mane does. Its research centers on triterpenes with antioxidant and anti-inflammatory activity — the proposed mechanism is protecting neurons from oxidative and inflammatory damage rather than directly stimulating nerve growth. Most of this evidence is preclinical: mouse studies show reduced neuronal apoptosis and mitigated age-related brain decline with long-term triterpenoid administration. A 2023 review in Medicinal Research Reviews put it plainly in its title — crucial knowledge on Reishi’s cognitive effects in humans is still lacking.

Cordyceps: More About Energy Than Cognition

Cordyceps has the least cognition-specific human evidence of the three. Most of its published research is about exercise performance — oxygen uptake, blood glucose stability, and reduced fatigue markers. The cognitive angle is mostly animal-model work: mice studies show cordycepin improving memory and learning in fatigue models, with proposed mechanisms including hippocampal neurogenesis, BDNF elevation, and neurotransmitter modulation. It’s a reasonable adjacent research area, but it’s a considerably thinner human evidence base than Lion’s Mane’s.

Bottom Line

Lion’s Mane is the mushroom with the closest mechanistic story to peptides like Semax — both are studied around the NGF pathway, and Lion’s Mane actually has more published human trial data behind it than some cognitive peptides do. Reishi and Cordyceps are legitimate research areas but currently rest on thinner, mostly preclinical evidence for cognition specifically. None of this makes one category strictly “better” than the other — they’re different tools with different evidence profiles, and for many people researching this space, the mushrooms are simply a legal, over-the-counter option while research peptides are not.

Explore More

• Semax vs Selank vs Dihexa vs Cerebrolysin — the peptide side of this comparison
• Semax Directory Page
• Cognitive Research Forum

Research Sources

• Lion’s Mane mild cognitive impairment trial and erinacine A Alzheimer’s trial summaries. Alzheimer’s Drug Discovery Foundation. alzdiscovery.org
• Acute effects of Hericium erinaceus extract on cognition and mood in healthy adults. Frontiers in Nutrition, 2025. frontiersin.org
• Luz et al. “Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking.” Medicinal Research Reviews, 2023. onlinelibrary.wiley.com
• Improvement of Learning and Memory Induced by Cordyceps Polypeptide Treatment. PMC. ncbi.nlm.nih.gov

Disclaimer: This article is for educational and informational purposes only and is not medical advice. Functional mushroom supplements and research peptides are different legal and regulatory categories — talk to a licensed healthcare provider before starting any supplement or research compound.